InvestorsHub Logo
Followers 103
Posts 4897
Boards Moderated 0
Alias Born 10/06/2011

Re: jour_trader post# 358056

Tuesday, 06/22/2021 3:43:25 PM

Tuesday, June 22, 2021 3:43:25 PM

Post# of 413767
The impact of the pandemic is little understood by many...and, among others, Elite has been impacted. Let me expand on that...

I listened to presentations given by a biotech with a relatively new commercialized drug talking on a Zoom conference with Goldman Sachs and Raymond James. The nexus of the agreement between both company analysts and the biotech is this...

Even now, healthcare workers able to write scripts are still only having "live interactions" (aka seeing patients) and able to write scripts or provide hands on in-person healthcare 70% of where they were pre-pandemic (and please do not tell me how your PCP is different, this is an accepted industry wide number that all pharma is dealing with). Moreover, the belief is that it will take at least nine more months to achieve pre-pandemic levels of interactions. The salient point is that across the board commercial activities have led to a decline in Q-Q revenues by many pharma companies that have relatively new products they are commercializing. Elite's experience this past year is no different than others. However, according to the all-knowing Goldman Sachs, the belief is that not only will companies return to pre-pandemic sales but the expectation is an additional bump up resulting from pent-up or suppressed demand.

Despite arguments to the contrary, Elite is not operating in a vacuum and does not control the external environment.

As to this...

We have heard management speak to future revenues, PPS, NASDAQ ambitions, FDA submissions, etc that never came to fruition.



I thought I was crystal clear that what Elite wanted to do was impaired by the ability to fund its development, which has been ameliorated by becoming CFP. As for the p/s, I thought I was equally clear...the very fact that the p/s has been suppressed was evidence of a malignant intent to make it difficult for it to fund the business through LPC. And...those days are gone. But the effort to play games remains with the p/s remains, but I already provided a link on that three times and need not do it again.

As to uplisting to the Nasdaq...at this point is it not clear what that really means?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News